Učitavanje...
PSA, PSA derivatives, proPSA and prostate health index in the diagnosis of prostate cancer
Currently, prostate- specific antigen (PSA) is the most common oncological marker used for prostate cancer screening. However, high levels of PSA in benign prostatic hyperplasia and prostatitis decrease the specificity of PSA as a cancer marker. To increase the specificity of PSA, PSA derivatives an...
Spremljeno u:
| Izdano u: | Turk J Urol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Turkish Association of Urology
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4548380/ https://ncbi.nlm.nih.gov/pubmed/26328156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tud.2014.94547 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|